Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jack H. Dean currently holds 2,150 shares of Acurx Pharmaceuticals, Inc. (ACXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jack H. Dean has been a net buyer of ACXP stock. They have purchased $52.0K and sold $0 worth of shares.
Jack H. Dean's most recent insider trade was on Apr 20, 2026, when they sold 2,150 shares at $0.00 per share.
Jack H. Dean serves as Executive at Acurx Pharmaceuticals, Inc. (ACXP). They have executed 4 insider transactions totaling $52.0K over their tenure at the company.
Jack H. Dean holds the position of Executive at Acurx Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Jack H. Dean has shown a buying trading pattern, with $52.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jack H. Dean was on May 21, 2014, when they purchased $27.0K worth of DPRX shares. This transaction involved 3,000 shares at $9.00 per share.
Jack H. Dean currently owns 2,150 shares of Acurx Pharmaceuticals, Inc. (ACXP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jack H. Dean's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jack H. Dean has 4 Form 4 filings on record as an insider at Acurx Pharmaceuticals, Inc..
Set alerts for Jack H. Dean and 40,000+ other insiders.